熱門資訊> 正文

Maze Therapeutics任命新财务主管

2025-09-02 19:32

Maze Therapeutics (NASDAQ:MAZE) appointed Misbah Tahir as chief financial officer, effective immediately.
Mr. Tahir brings more than 20 years of financial and strategic experience in the biopharmaceutical industry. He most recently served as CFO of IGM Biosciences.

More on Maze Therapeutics

Historical earnings data for Maze Therapeutics
Financial information for Maze Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。